大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/03 | 4,648 | 4,648 | 4,562 | 4,579 | +24 | +0.5% | 1,265,200 |
2022/08/02 | 4,670 | 4,681 | 4,550 | 4,555 | -183 | -3.9% | 1,045,800 |
2022/08/01 | 4,722 | 4,770 | 4,711 | 4,738 | -16 | -0.3% | 1,013,300 |
2022/07/29 | 4,944 | 4,948 | 4,691 | 4,754 | -149 | -3% | 1,710,200 |
2022/07/28 | 4,899 | 4,920 | 4,826 | 4,903 | +7 | +0.1% | 1,241,900 |
2022/07/27 | 4,866 | 4,913 | 4,786 | 4,896 | +9 | +0.2% | 1,530,800 |
2022/07/26 | 4,942 | 4,958 | 4,876 | 4,887 | -69 | -1.4% | 792,900 |
2022/07/25 | 4,955 | 4,990 | 4,923 | 4,956 | +4 | +0.1% | 665,100 |
2022/07/22 | 4,976 | 4,983 | 4,900 | 4,952 | -26 | -0.5% | 797,300 |
2022/07/21 | 4,902 | 4,987 | 4,899 | 4,978 | +39 | +0.8% | 840,900 |
2022/07/20 | 4,906 | 4,949 | 4,879 | 4,939 | +76 | +1.6% | 955,300 |
2022/07/19 | 4,902 | 4,914 | 4,838 | 4,863 | -54 | -1.1% | 645,500 |
2022/07/15 | 4,941 | 4,966 | 4,898 | 4,917 | -21 | -0.4% | 866,000 |
2022/07/14 | 4,910 | 4,960 | 4,875 | 4,938 | +10 | +0.2% | 915,300 |
2022/07/13 | 4,937 | 4,976 | 4,915 | 4,928 | -18 | -0.4% | 809,400 |
2022/07/12 | 4,954 | 4,985 | 4,924 | 4,946 | -38 | -0.8% | 1,058,400 |
2022/07/11 | 4,949 | 5,000 | 4,920 | 4,984 | +105 | +2.2% | 1,163,900 |
2022/07/08 | 4,950 | 4,962 | 4,832 | 4,879 | -121 | -2.4% | 1,593,500 |
2022/07/07 | 4,972 | 5,000 | 4,923 | 5,000 | +65 | +1.3% | 1,391,000 |
2022/07/06 | 4,867 | 4,964 | 4,860 | 4,935 | +39 | +0.8% | 1,508,200 |
2022/07/05 | 4,881 | 4,896 | 4,830 | 4,896 | +14 | +0.3% | 1,055,000 |
2022/07/04 | 4,900 | 4,929 | 4,840 | 4,882 | +113 | +2.4% | 1,104,400 |
2022/07/01 | 4,858 | 4,904 | 4,753 | 4,769 | -49 | -1% | 1,080,500 |
2022/06/30 | 4,815 | 4,861 | 4,811 | 4,818 | +13 | +0.3% | 1,439,500 |
2022/06/29 | 4,850 | 4,878 | 4,793 | 4,805 | -130 | -2.6% | 1,703,800 |
2022/06/28 | 4,809 | 4,950 | 4,797 | 4,935 | +138 | +2.9% | 1,611,700 |
2022/06/27 | 4,567 | 4,805 | 4,518 | 4,797 | +245 | +5.4% | 2,104,900 |
2022/06/24 | 4,560 | 4,565 | 4,499 | 4,552 | +27 | +0.6% | 702,600 |
2022/06/23 | 4,490 | 4,554 | 4,490 | 4,525 | +30 | +0.7% | 754,300 |
2022/06/22 | 4,465 | 4,517 | 4,453 | 4,495 | +59 | +1.3% | 735,100 |
2022/06/21 | 4,430 | 4,462 | 4,379 | 4,436 | +29 | +0.7% | 904,200 |
2022/06/20 | 4,413 | 4,447 | 4,380 | 4,407 | +47 | +1.1% | 552,200 |
2022/06/17 | 4,322 | 4,388 | 4,307 | 4,360 | ±0 | ±0% | 1,339,700 |
2022/06/16 | 4,378 | 4,415 | 4,358 | 4,360 | +49 | +1.1% | 704,000 |
2022/06/15 | 4,394 | 4,395 | 4,306 | 4,311 | -72 | -1.6% | 764,400 |
2022/06/14 | 4,406 | 4,426 | 4,366 | 4,383 | -74 | -1.7% | 862,500 |
2022/06/13 | 4,381 | 4,464 | 4,381 | 4,457 | +21 | +0.5% | 835,800 |
2022/06/10 | 4,474 | 4,474 | 4,424 | 4,436 | -29 | -0.6% | 1,085,100 |
2022/06/09 | 4,450 | 4,492 | 4,431 | 4,465 | +36 | +0.8% | 865,800 |
2022/06/08 | 4,396 | 4,433 | 4,365 | 4,429 | +75 | +1.7% | 796,600 |
2022/06/07 | 4,330 | 4,379 | 4,320 | 4,354 | -11 | -0.3% | 801,400 |
2022/06/06 | 4,320 | 4,376 | 4,316 | 4,365 | +24 | +0.6% | 732,600 |
2022/06/03 | 4,342 | 4,368 | 4,321 | 4,341 | +24 | +0.6% | 771,000 |
2022/06/02 | 4,375 | 4,383 | 4,304 | 4,317 | -65 | -1.5% | 954,300 |
2022/06/01 | 4,340 | 4,432 | 4,324 | 4,382 | +93 | +2.2% | 1,198,600 |
2022/05/31 | 4,391 | 4,422 | 4,289 | 4,289 | -88 | -2% | 5,562,700 |
2022/05/30 | 4,349 | 4,410 | 4,330 | 4,377 | +46 | +1.1% | 1,250,000 |
2022/05/27 | 4,400 | 4,409 | 4,313 | 4,331 | -25 | -0.6% | 889,400 |
2022/05/26 | 4,409 | 4,441 | 4,354 | 4,356 | -71 | -1.6% | 1,167,200 |
2022/05/25 | 4,475 | 4,482 | 4,426 | 4,427 | -40 | -0.9% | 978,000 |
751~
800
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム